Anne A. Finucane - Nov 21, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
Director
Signature
/s/ Anne M. Finucane
Stock symbol
CVS
Transactions as of
Nov 21, 2024
Transactions value $
$125,625
Form type
4
Date filed
11/25/2024, 05:41 PM
Previous filing
Oct 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 7.23K Nov 21, 2024 Direct
holding CVS Common Stock 25.2K Nov 21, 2024 By Finucane Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Deferred Stock Units Award $126K +2.2K +22.06% $57.10 12.2K Nov 21, 2024 Common Stock 2.2K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
F2 Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.